The mechanism of insulin action is a central question in biology with important ramifications into many areas of human disease, including diabetes, obesity, atherosclerosis and hypertension. Studies of the nematode Caenorhabditis Elegans have provided important insight into insulin action. In this simple metazoan, mutations of the insulin/IGF-1 receptor homologue Daf-2 gene prolong life span, decrease metabolic activity and increase fat accumulation. This characteristic stage, referred to as the dauer stage, can be rescued by mutations of the Daf-16 gene. This suggests that Daf-16 is a negative regulator of insulin/IGF-1 receptor signaling in C. Elegans. Daf-16 encodes a forkhead transcription factor. The investigators have shown that FKHR, the closest mammalian homologue of Daf-16, is an insulin-regulated transcription factor. In hepatocytes, insulin phosphorylates FKHR on at least three different amino acid residues through a hierarchical cascade initiated by the serine-threonine kinase, Akt. Insulin-dependent phosphorylation inhibits the ability of FKHR to stimulate transcription of prototypic insulin-responsive genes like PEPCK and IGFBP-1, in addition to genes that regulate apoptosis. Based on the tissue distribution of the three mammalian Fkhr genes in mice (Fkhr, FkhrII, Afx), as well as their seemingly different phosphorylation patterns, the investigators propose to test the hypothesis that FKHR mediates insulin action in liver and beta cells. There are two specific aims in this proposal.
In aim 1, the investigators will address the role of FKHR in insulin-dependent glucose production in vitro. The investigators will first ask whether hepatic glucose production can be regulated by introducing dominant negative or constitutively active mutant FKHRs into hepatocytes from either normal mice or insulin receptor-deficient mice. Next the investigators will address whether differences in the phosphorylation patterns of renal and hepatic FKHR proteins can account for the tissue-specific ability of insulin to suppress hepatic, but not renal gluconeogenesis.
In aim 2, the investigators will introduce null alleles of FKHR in mice using conditional mutagenesis and ask whether selective ablation of FKHR in liver and/or beta cells can rescue diabetes in insulin resistant mice by reducing glucose output or preventing beta cell apoptosis. Conversely, the investigators will attempt to induce diabetes in mice by means of a constitutively active mutant FKHR, generated through a novel """"""""knock-in"""""""" approach. These investigations will shed new light onto the mechanisms by which insulin resistance causes hyperglycemia, and disclose new approaches to the treatment of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK057539-01A1
Application #
6258559
Study Section
Metabolism Study Section (MET)
Program Officer
Blondel, Olivier
Project Start
2001-01-01
Project End
2005-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
1
Fiscal Year
2001
Total Cost
$400,675
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Langlet, Fanny; Tarbier, Marcel; Haeusler, Rebecca A et al. (2018) microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function. Mol Metab 17:49-60
Accili, Domenico (2018) Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes 67:1701-1709
Haeusler, Rebecca A; McGraw, Timothy E; Accili, Domenico (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31-44
Langlet, Fanny; Haeusler, Rebecca A; Lindén, Daniel et al. (2017) Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling. Cell 171:824-835.e18
Kim-Muller, Ja Young; Kim, Young Jung R; Fan, Jason et al. (2016) FoxO1 Deacetylation Decreases Fatty Acid Oxidation in ?-Cells and Sustains Insulin Secretion in Diabetes. J Biol Chem 291:10162-72
Accili, D; Talchai, S C; Kim-Muller, J Y et al. (2016) When ?-cells fail: lessons from dedifferentiation. Diabetes Obes Metab 18 Suppl 1:117-22
Cook, Joshua R; Matsumoto, Michihiro; Banks, Alexander S et al. (2015) A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism. Diabetes 64:1951-65
Pajvani, Utpal B; Accili, Domenico (2015) The new biology of diabetes. Diabetologia 58:2459-68
Cook, Joshua R; Langlet, Fanny; Kido, Yoshiaki et al. (2015) Pathogenesis of selective insulin resistance in isolated hepatocytes. J Biol Chem 290:13972-80
Ren, Hongxia; Cook, Joshua R; Kon, Ning et al. (2015) Gpr17 in AgRP Neurons Regulates Feeding and Sensitivity to Insulin and Leptin. Diabetes 64:3670-9

Showing the most recent 10 out of 66 publications